Corona Virus: Scientists at Oxford University release corona antivirus timeline when human experiments begin

Viruses are easily spread, and the vast majority of the world's population is still vulnerable. Vaccines can be protected by training people's immune systems to fight the virus to protect them from getting sick.

The Corona Virus vaccine, developed by Oxford University, began human experimentation with the first two patients injected with a potential vaccine. At the press conference on April 22, Health Minister Matt Hancock said the "Oxford Project vaccine will go into effect this Thursday."

The vaccine was developed by a team at Oxford University within three months. Sarah Gilbert, Department of Vaccine at the Jenner Institute, led a preclinical study.

"Personally, I have high confidence in this vaccine," she said.

"Of course, we need to test it and get data from humans. We must show that it actually works and stops people infected with coronavirus before using the vaccine in more populations."

Since the vaccine contains only one dose and does not use a replication virus, it cannot infect individuals who have been vaccinated. The adenovirus vector is a very well-studied vaccine type and has been used safely in many people, including HIV vaccine tests.

How will Corona Antivirus work?

• Scientists take the spike protein gene on the surface of the corona virus and put it in a harmless virus to make a vaccine.
• This is injected into the patient's body

• When the vaccine enters the cells, corona virus spike proteins begin to form.
• This stimulates the immune system to produce antibodies and activate killer T-cells to destroy infected cells.
• When the patient sees the corona virus again, T-cells and antibodies are triggered to fight the virus.